glp-1 drugs and alcohol consumption How Are Impacting Beverage Sales As GLP-1 drugs for weight

Reddy IA, Stanwood GD, Galli A

For patients planning natural conception or preparing for ART, how much weight is lost is merely the starting point

In contrast, tirzepatide, a dual GLP-1 RA (GIP/GLP-1 RA) [1], was associated with a markedly larger effect, with a pooled mean difference of - 23.80 events/hour (95% CI: 29.62 to 17.98

While tirzepatide has substantial evidence supporting its approval for obesity treatment, Lilly has shown it to deliver better results than semaglutide in the SURMOUNT-5 trial

Long-term safety continues to be monitored as these medications remain relatively new

Curcumin shows similar potential in animal models